Company / R&D per Share
Vanda Pharmaceuticals Inc. R&D per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$1.32
FY2025
5-year range
$0.89 / $1.49
FY2021-FY2025
Trend
-11.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
R&D per Share has fluctuated over the past 10 years, ranging from $0.45 in FY2016 to $1.49 in FY2024.
Based on SEC 10-K filings.
1.32 in FY2025 with a 5-year CAGR of +10.1%.
Remained stable around $1.32 over the past 2 years.
R&D per Share over time
Growth rates
- 3-Year CAGR
- +9.8%
- 5-Year CAGR
- +10.1%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, r&d per share decreased 11.6% year-over-year.
- Peak r&d per share was recorded in FY2024.
- Lowest r&d per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -3.96 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.32 | -11.6% |
| FY2024 | $1.49 | +12.3% |
| FY2023 | $1.33 | +33.5% |
| FY2022 | $0.99 | +12.1% |
| FY2021 | $0.89 | +8.9% |
| FY2020 | $0.81 | +10.8% |
| FY2019 | $0.73 | +13.2% |
| FY2018 | $0.65 | -2.0% |
| FY2017 | $0.66 | +47.5% |
| FY2016 | $0.45 | -34.6% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026